There are 313 resources available
The problems of agnostic drug development
Presenter: Francesco Pignatti
Session: Methodology (tumour agnostic)
Resources:
Slides
Webcast
19O - AIMET: A EURACAN multicenter pilot study of aromatase inhibitors plus metformin on recurrent granulosa cell tumors
Presenter: Olesya Solheim
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
Invited Discussant 62O, 57O and 19O
Presenter: Robin Jones
Session: Proffered Paper session
Resources:
Slides
Webcast
The ESMO Tumour-Agnostic Classifier as part of tumour-agnostic drug development
Presenter: Christoph Benedikt Westphalen
Session: Methodology (tumour agnostic)
Resources:
Slides
Webcast
Q&A and discussion
Session: Genitourinary cancers
Resources:
Webcast
Balancing decsions between surgery and radiation
Presenter: Bertrand Baujat
Session: Head and neck cancers
Resources:
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session
Resources:
Webcast
Q&A and discussion
Session: Methodology (tumour agnostic)
Resources:
Webcast
Q&A and discussion
Session: Head and neck cancers
Resources:
Webcast
37O - Plasma circulating tumor DNA (ctDNA) as a clinically relevant biomarker for disease monitoring and prognostication in metastatic pheochromocytoma and paraganglioma (mPPGL)
Presenter: Rodrigo Toledo
Session: Proffered Paper session
Resources:
Abstract